- Sees opportunity in the passing of the new Farm Bill
- Signs new chief sales officer to distribute CBD products nationwide
- Orders first commercial production run of Hygee Kits
The passing of the new Farm Bill is big news for companies like Earth Science Tech, Inc. (OTCQB: ETST) that work within the cannabis industry. ETST is a Florida-based biotechnology company focused on cannabis and cannabinoid research and development, nutraceuticals, pharmaceuticals and medical devices. The newly passed 2018 Farm Bill removed hemp (including hemp-derived cannabinoids containing less than 0.3 percent THC) from the Controlled Substances act. According to New Frontier cannabis market data, the American CBD market is now projected to reach $2.3 billion in revenue by 2022.
ETST is taking advantage of the opportunities now afforded by the 2018 Farm Bill. In a recent press release (http://cnw.fm/jn2M9), the company announced a change in staff. David Barbash has been signed on as its new chief sales officer, beginning in 2019. He brings more than 20 years of new business development experience and is a proven negotiator, manager and motivator. Barbash will be responsible for distributing CBD products through his nationwide retail accounts. Jill Buzan, ETST’s current chief sales officer, is transitioning to direct ETST’s sales in Florida.
In a news release, Nickolas S. Tabraue, president, director and chairman of ETST, stated, “[Barbash’s] expertise and enthusiasm will be tremendous assets as we ride the wave opportunity afforded by the legalization of hemp cultivation and hemp-derived CBD in the United States.”
The company also recently announced its first commercial production run of Hygee Kits (http://cnw.fm/OK2rd). The self-sampling kits enable women to discreetly test for sexually transmitted infections (STIs) such as chlamydia. The World Health Organization (WHO) recommends that women between the ages of 15 and 25 who are sexually active get tested yearly for chlamydia. This demographic represents a market of approximately 500 million women worldwide. Initial marketing for this first product run will target North America, South America, Asia and Africa. Packaging for the kits will be available in English, French, Portuguese, Spanish, Vietnamese and Arabic.
Hygee is convenient, efficient, affordable and anonymous. It is considered a ‘mistake-proof’ medical device that comes with simple instructions that allow for successful use on the first try. According to WHO, there are approximately 130 million new chlamydia cases diagnosed each year. Pregnant women are screened to minimize the risk of transmitting the infection to their babies during childbirth. Chlamydia is a global issue, and sales of Hygee are projected to reach between $1.5 million and $2.5 million in the first year. Second year sales are projected to reach $1 million monthly, and, by the third year, sales are expected to rise to $20 million yearly. By 2023, the global medical device market is anticipated to surpass $400 billion (http://cnw.fm/NBS6s). While Hygee is set to be launched early in 2019 for the detection of chlamydia, it is only the beginning in terms of what the company has planned in the medical device space.
“We believe that ETST has developed the best tool on the market to fight STIs, which will provide an exceptional service to women who use Hygee,” added Tabraue. “The production of the first batch of Hygee is very exciting. Our team believed in the success of Hygee from the first day we acquired it. Now, we will do everything possible to spread this fabulous medical device everywhere on the planet to protect women and their future babies from the terrible, adverse effects of chlamydia and other STIs.”
For more information, visit the company’s website at www.EarthScienceTech.com
More from CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
CannabisNewsWire is at the epicenter of the Cannabis Revolution.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com